HOME >> BIOLOGY >> NEWS
Careful Honeybee Breeding Combats Tracheal Mite Pests

COLUMBUS, Ohio -- A study at Ohio State University has shown that selective breeding helps honeybees develop resistance to tracheal mites, pests that beekeepers normally control with insecticide.

The research indicates that with a combination of selective breeding and other natural controls, beekeepers may maintain healthy hives without relying on chemical controls.

Before Ohio State began selectively breeding for mite resistance, about half of the bees at the university had tracheal mites. As of spring 1997, the number had dropped to nearly undetectable levels, without the use of chemicals.

“The problem with treating bee hives with chemicals is that the honey could become contaminated,” said Susan Cobey, apiarist at Ohio State. “The mites eventually develop a resistance to the chemicals anyway. We are trying to develop more natural techniques for controlling tracheal mites that will be practical for commercial beekeepers.”

Cobey explained that tracheal mites are but one of the problems facing honeybees in North America: cold winters, wet springs, and pesticides have all combined to lower the bee population in recent years. In fact, wild populations of bees in the United States are nearly extinct.

Beekeepers currently manage about 3 million colonies of honeybees in the United States, and they have suffered losses as well, although not as severe. Estimates of managed bee colony losses to mites vary from state to state.

In a recent issue of the American Bee Journal, Cobey explained how beekeepers could control tracheal mites effectively over the long term -- by breeding bees that carry the genetic traits that help them combat the mites.

Cobey said that such genetic resistance occurs naturally. Bees in Europe, where scientists first discovered tracheal mites in the 1920s, have long since develo
'"/>

Contact: Susan Cobey
Cobey.1@osu.edu
(614) 292-7928
Ohio State University
20-Jan-1998


Page: 1 2 3 4

Related biology news :

1. Honeybee gene find ends 150-year search
2. USDA establishes Honeybee Genetics and IPM Center
3. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon
4. Honeybees In The Wild Nearly Gone In North America
5. Breeding programs should incorporate mate choice
6. Invading Pests Harm People, Plants And Animals
7. Dust Mite Behavior May Show New Ways To Control Pests
8. Termites Attraction To Small Amounts Of Carbon Dioxide Lures Pests To Their Deaths

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Careful Honeybee Breeding Combats Tracheal Mite Pests

(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)...  Ascendis Pharma A/S, a biotechnology company that ... unmet medical needs, today announced positive six-month interim ... to evaluate once-weekly TransCon Growth Hormone in children ... analysis consists of 25 patients, representing approximately 50% ... completing all six months of treatment. ...
(Date:12/13/2014)... The DNA Microarray market market was ... expected to grow at a CAGR of 15.2% ... TOC of the DNA Microarray for an in-depth ... help of various tables and figures. , ... consists of instrument, consumables, and services, where the ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4
Cached News: